Willem Jan van Weelden

7PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Other education not elsewhere classifiedPredictive and prognostic markersEconometric and statistical methodsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
Hormonal therapy or chemotherapy for advanced endometrial cancer? A mixed-methods study assessing physicians' attitudes.

|Oct 10, 2023
Author reply.

Willem Jan van Weelden, Philine B Birkendahl, Roy I Lalisang

|Oct 03, 2023
Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification.

Johanna M A Pijnenborg, Willem Jan van Weelden, Casper Reijnen

|Oct 20, 2022
The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta-analysis.

Willem Jan van Weelden, Philine B Birkendahl, Roy I Lalisang

|Jun 09, 2020
Oestrogen receptor pathway activity is associated with outcome in endometrial cancer.

Willem Jan van Weelden, Louis J M van der Putten, Márcia A Inda

|Aug 27, 2019
Predictive value of estrogen and progesterone receptors in endometrial hyperplasia and cancer.

Willem Jan van Weelden, Casper Reijnen, Johanna Ma Pijnenborg

Pageof 2

Frequent Collaborators

3 joint publications

Johanna Ma Pijnenborg

2 joint publications

Casper Reijnen

1 joint publications

Sofia Xanthoulea